Target intelligence / Profile preview

MicroRNA-597 (miR-597)

Target
miR-597
Molecular classification
microRNA, Non-coding RNA, Other
01

Overview

MicroRNA-597 (miR-597) is a small, non-coding RNA molecule classified as a microRNA, involved in the post-transcriptional regulation of gene expression. It acts primarily by binding to complementary sequences in the 3′ untranslated regions (3′UTRs) of target mRNAs, such as FOS-like antigen 2 (FOSL2), leading to mRNA degradation or translational repression[1][3][4]. miR-597 is frequently downregulated in several human cancers, including breast cancer and colorectal cancer, where it functions as a tumor suppressor by inhibiting cell proliferation, migration, invasion, and promoting apoptosis[1][3][4]. In myelodysplastic syndromes, miR-597 is found to be upregulated and induces apoptosis by downregulating FOSL2[4]. Due to its disease associations and role in regulating malignancy-related pathways such as EMT and cell cycle progression, miR-597 (and its expression levels) may serve as a biomarker for diagnosis or prognosis in certain cancers and is considered a potential therapeutic target[1][3][4].

Other names
hsa-miR-597MIR597hsa-mir-597mir-597MIRN597
02

Biological functions

Regulation of gene expressionInhibition of cell proliferationCell cycle regulationInhibition of migration and invasionInduction of apoptosisSuppression of epithelial-to-mesenchymal transition (EMT)
03

Disease associations

CancerBreast cancerColorectal cancerMyelodysplastic syndromes (MDS)Hepatocellular carcinomaNon-small cell lung cancer
04

Safety considerations

Potential off-target gene regulation typical of microRNA therapeuticsBroad target spectrum may lead to unintended biological effects
05

Biomarkers

miR-597 expression (in cancer types)FOSL2 expression (inverse correlation, especially in tumors)

Beyond the preview

Go deeper on MicroRNA-597 (miR-597).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-597 (miR-597).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call